Rescue Bio Inc.
Rescue Bio Inc.
  • Home
  • Publications
  • Team
  • Science
  • More
    • Home
    • Publications
    • Team
    • Science
  • Home
  • Publications
  • Team
  • Science

Advancing Immunotherapy

Advancing ImmunotherapyAdvancing ImmunotherapyAdvancing Immunotherapy

Developing Therapies for ARDS, SIRS, TBI and Spinal Cord Injury

Contact Us

Advancing Immunotherapy

Advancing ImmunotherapyAdvancing ImmunotherapyAdvancing Immunotherapy

Developing Therapies for ARDS, SIRS, TBI and Spinal Cord Injury

Contact Us

About Us

What is our Technology

 We have developed a suite of monoclonal antibodies targeting CD11d which plays a role in immune and inflammatory responses.   

How We Help

  

  • Therapeutic candidates identified to a novel target  
  • Short treatment course immediately following injury
  • Treatment is non-depleting and short acting        
  • Acute respiratory distress syndrome (ARDS), Spinal cord injury, Traumatic brain injury, Systemic inflammatory response syndrome (SIRS)

Experience the Difference

Our research has defined the role of CD11d in inflammation. Through the use of immunological, molecular and cell biological techniques, we have defined the phenotype and function of different monocyte subsets that infiltrate the site of inflammation. 

The second focus of our research is the development of novel therapeutic vaccine approaches for cancer. The current emphasis is in developing antigen presenting cell-based therapeutic vaccines with a particular interest in dendritic cells. 

Subscribe

Sign up to hear from us.

Our Aproach

Define Target

Clinical Approval

Drug Development

Our lab has defined certain targets and their role in important disease indications.  From that discovery we have filed patents and perform preclinical drug development studies.

 

Drug Development

Clinical Approval

Drug Development

Once the target has been identified we validate drug candidates and prepare them for clinical evaluation through a network of trusted partners and service providers.


Clinical Approval

Clinical Approval

Clinical Approval

Once we have performed the necessary regulatory steps through the proper clinical phases we are prepared to conduct the necessary studies for eventual market approval and market launch.


Our Partners

Reviews

Contact Us

Please send us a message or call us for an appointment. 

Rescue Bio Inc.

507 Billybrook Crescent, London, Ontario N5X 2Y9, Canada

jleushner@rescue-bio.com 1(519) 933-7867

Address

 100 Perth Dr, London, ON N6A 5K8 

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Rescue Bio Inc.

Copyright © 2022 Rescue Bio Inc. - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept